FGFR4 N535K Recombinant Human Active Protein Kinase
FGFR4 is a transcriptional target of the PAX3-FOXO1 fusion gene. FGFR4 expression is significantly higher in rhabdomyosarcoma. FGFR3 K650E is a mutant of FGFR3 that may be present in rhabdomyosarcoma. FGFR4 N535K Recombinant Human Active Protein Kinase is a recombinant FGFR4 N535K protein that can be used to study FGFR4 N535K-related functions[1].
Product Specifications
UNSPSC
12352211
Target
FGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
[FGFR4N535KRecombinantHumanActiveProteinKinase]
References & Citations
[1]Timothy McKinnon, et al. Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma. Oncogene. 2018 May;37 (20) :2630-2644.
Shipping Conditions
Room temperature
Scientific Category
Enzyme
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C8297-98W-ML405 100 µL
CXCL9 (C-X-C Motif Chemokine 9, CMK, Gamma-interferon-induced Monokine, Humig, Monokine Induced by gamma Interferon, MIG, Small-inducible Cytokine B9, SCYB9) (MaxLight 405) discontinued
Ask
View Details ![Rabbit Polyclonal Pannexin-1 Antibody [DyLight 350]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
GTR15361313 1 Vial
Lentiviral human CNOT6L sgRNA gene knockout kit - Lentiviral human CNOT6L sgRNA gene knockout kit (plasmid)
Ask
View Details